Mycoplasma pneumoniae is generally recognized as a cause of a benign, self-limited respiratory infection that occurs primarily in children and young adults (2). Although severe mycoplasmal respiratory illness has been uncommon, some reports (15, 16) have suggested that the disease spectrum attributable to M. pneumoniae is more serious than previously thought and that severe pulmonary involvement can occur in otherwise healthy children and adults of all age groups. In addition, extrapulmonary complications involving the skin, cardiovascular, gastrointestinal, or central nervous systems (or any combination of these) are frequently associated with M. pneumoniae infections (1, 15, 16) .
Modified New York City (MNYC) medium and PPLO medium without methylene blue (PPLO agar) were compared for their ability to support the growth of Mycoplasma pneumoniae from clinical specimens. Pharyngeal specimens were collected from 1,070 college students who visited the Syracuse University Student Health Center. Of these patients, 623 were symptomatic for respiratory infection, and the remaining 447 were asymptomatic for respiratory illness. Throat swabs were inoculated into PPLO broths, and these broths were subcultured onto MNYC medium and PPLO agar after 3 and 14 days of incubation. A total of 222 (20.7%) clinical isolates of M. pneumoniae were recovered on these solid media, with the majority of the isolates (196) recovered from symptomatic patients. All isolates grew on MNYC medium, whereas five isolates failed to grow on PPLO agar. All isolates of M. pneumoniae recovered from symptomatic patients were detected on MNYC medium within 1 to 5 days of incubation, whereas 5 to 7 days of incubation were required before mycoplasmal growth was detected on PPLO agar. Over 86% of these mycoplasma isolates were detected on MNYC medium within 3 days of incubation and before the detection of any mycoplasmal growth on PPLO agar. A similar pattern of recovery times was observed for mycoplasmas isolated from asymptomatic patients. The results of this study have shown that MNYC medium is Setter than PPLO agar in supporting the rapid growth of M. pneumoniae from clinical specim-ns after 72-h blind subculture in PPLO glucose broth.
Mycoplasma pneumoniae is generally recognized as a cause of a benign, self-limited respiratory infection that occurs primarily in children and young adults (2) . Although severe mycoplasmal respiratory illness has been uncommon, some reports (15, 16) have suggested that the disease spectrum attributable to M. pneumoniae is more serious than previously thought and that severe pulmonary involvement can occur in otherwise healthy children and adults of all age groups. In addition, extrapulmonary complications involving the skin, cardiovascular, gastrointestinal, or central nervous systems (or any combination of these) are frequently associated with M. pneumoniae infections (1, 15, 16) .
The diagnosis of an M. pneumoniae infection is confirmed by either culture or specific serology (13) . Conventional culture methods involve the use of specialized media such as E agar (13) and modified formulations of Hayflick's PPLO broth and agar (19) , whereas serological assays test for significant changes in specific mycoplasmal antibody titers in acute and convalescent patient sera (14) . Each of these procedures is not without its limitations, since several weeks to a month may elapse before a laboratory diagnosis of mycoplasma infection can be established. In addition, these methods involve the use of specialized procedures which are not readily available in most clinical laboratories.
In a previous investigation (9), we performed a preliminary study that compared modified New York City (MNYC) medium with conventional mycoplasma media for ability to support the growth of stock strains of M. pneumoniae. The results of that study showed that MNYC medium is suitable for supporting the growth of stock strains of M. pneumoniae and that growth can be detected a minimum of 5 to 6 days sooner than with conventional mycoplasmal media.
Since the MNYC formulation was able to support the growth of M. pneumoniae within a significantly shorter period of time, we reasoned that perhaps this medium could be used in the recovery of M. pneumoniae from clinical specimens. The purpose of this investigation was (i) to compare MNYC medium with a conventional mycoplasmal medium, such as PPLO agar with- (19) .
RESULTS
A total of 222 (20.7%) clinical isolates of M. pneumoniae were recovered from the patient population of 1,070 college students. The majority of these isolates (196) were recovered from the 623 symptomatic patients, whereas the remaining 26 isolates were recovered from the 447 asymptomatic patients. Table 1 shows the comparative recovery rates of M. pneumoniae on MNYC and PPLO media from the symptomatic patients after subculture from the PPLO enrichment broth after 72 h of incubation. All isolates of M. pneumoniae were detected on MNYC medium within 1 to 5 days of incubation, whereas 5 to 7 days of incubation were required before mycoplasmal growth was detected on PPLO agar. Importantly, 86.7% of all M. pneumoniae isolates were detected on MNYC medium within 3 days of incubation and before the detection of any mycoplasmal growth on PPLO agar. Two isolates of M. pneumoniae failed to grow on PPLO agar but were recovered on MNYC medium after subculture from the PPLO broth. There were no isolates of M. pneumoniae that grew on PPLO agar but failed to grow on MNYC medium.
The comparative recovery rates of M. pneumoniae on MNYC and PPLO media from the control patients after 3-day blind subculture from the PPLO glucose broths are shown in Table 2 . All isolates of M. pneumoniae were recovered on MNYC medium within 3 to 5 days of incubation, with 77% of the isolates recovered within 4 days of incubation. PPLO medium required 5 to 7 days of incubation before the detection of mycoplasmal growth. All isolates of M. pneumoniae that were recovered on PPLO agar grew on MNYC medium. However, three isolates that were recovered on MNYC medium after blind subcultures from the PPLO broth failed to grow on PPLO medium.
All isolates of M. pneumoniae were recovered on solid media after blind subculture from the PPLO glucose broth after 3 days of incubation, even though many of these broths did not show any evidence of mycoplasmal growth as evidenced by color change or turbidity. Prolonged incubation of the PPLO glucose broth for 14 days followed by blind subculture onto MNYC and PPLO media did not result in any additional isolates of M. pneumoniae. Only 13 (1.2%) of the 1,070 clinical specimens were observed to give false-positive reactions in the PPLO glucose broth, as evidenced by a color change of the broth indicator but with failure to recover mycoplasma on solid media after subculture. All of these false-positive reactions occurred within 4 days of incubation of the PPLO glucose broth. Five of these 13 specimens were from symptomatic patients. DISCUSSION Within recent years, new formulations of media have been developed that have been reported to support the improved growth of mycoplasma from clinical specimens. SP-4 medium, originally developed by Tully and his co-workers (18) for the cultivation of spiroplasmas, was found to enhance the isolation of M. pneumoniae from clinical specimens (17) . Although this medium was reported to be superior to diphasic medium with methylene blue for the isolation of M. pneumoniae, 2 to 3 weeks of incubation was required for the detection of mycoplasma growth on this medium.
New York City (NYC) medium has also been reported to support the growth of various human mycoplasmas (5, 7) . Although Faur and her colleagues initially developed this medium for the isolation of pathogenic Neisseria spp. (3, 4, 6) , these same investigators (7) subsequently found that this medium would support the growth of Ureaplasma sp. and large-colony mycoplasma. We modified the original formulation of NYC medium and found that the MNYC medium would support the rapid growth of stock strains of M. pneumoniae (9) . In addition, we also found that modified formulations of NYC medium were superior to Martin-Lewis medium for the recovery of Neisseria gonorrhoeae from clinical specimens (8, 10, 11) .
The results of our current study have shown that MNYC medium is better than PPLO agar in supporting the rapid growth of M. pneumoniae from clinical specimens after 72-h blind subculture from PPLO glucose broth. These findings indicate that the combined use of preincubated PPLO glucose broth followed by subculture onto NYC medium results in the detection of colony growth within 4 to 6 days of specimen inoculation. As such, significant improvement can be achieved in reducing the incubation times required to isolate M. pneumoniae from clinical specimens.
No advantage was found in prolonged incubation of the PPLO glucose broth beyond 3 days. However, the PPLO glucose broths should be subcultured routinely onto MNYC medium after 3 days of incubation, since all isolates of M. pneumoniae were recovered on solid media after this subculture, even though no evidence of mycoplasmal growth was apparent in many of the broths.
There were no isolates of M. pneumoniae that grew on PPLO agar but failed to grow on MNYC medium. However, five isolates were recovered on MNYC medium that failed to grow on PPLO agar. Two of these isolates were recovered from symptomatic patients, whereas the remaining three strains were recovered from the control patient population. This discrepant isolation rate between the two media was not statistically significant.
Although MNYC medium supported a more rapid growth of M. pneumoniae than did PPLO agar for isolates from both the symptomatic and the asymptomatic patients, longer incubation times were required to detect mycoplasma growth for isolates from the asymptomatic patient population. Over 96% of the M. pneumoniae isolates from the symptomatic patients were recovered on MNYC medium within 4 days of incubation, whereas 77% of the isolates were recovered from the control patients within the same time period. This result is probably attributable to inoculum effect since asympto-VOL. 17, 1983 on August 14, 2017 by guest http://jcm.asm.org/ Downloaded from matic patients are likely to be carrying fewer mycoplasma than individuals symptomatic for respiratory disease.
In summary, the results of this study have shown that MNYC medium supports the enhanced growth of M. pneumoniae from clinical specimens and, when used in conjunction with PPLO glucose broth, significantly reduces the incubation times required to establish the cultural diagnosis of M. pneumoniae infection.
